跳至主要内容
临床试验/JPRN-UMIN000028909
JPRN-UMIN000028909招募中未知

Evaluating the safety and efficacy of oocyte and embryo vitrification for fertility preservation - Evaluating the safety and efficacy of oocyte and embryo vitrification for fertility preservation

Keio University0 个研究点目标入组 43 人开始时间: 2017年9月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
43

研究概览

简要总结

Gonadotoxic treatment resulted in fewer oocytes. Although anti-Mullerian hormone levels were lower in the post-gonadotoxic treatment group than in the pre-gonadotoxic treatment group, oocyte maturation rates were higher in the post-gonadotoxic treatment group than in the pre-gonadotoxic group.

研究设计

研究类型
Interventional

入排标准

年龄范围
15years-old 至 45years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1. Freezing 1) The patients who cannot realize or obtain informed consent. 2) The patients judged to be inappropriate for the study by the physicians. 3) The case to delay treatments because of fertility preservation. 2. Fertilization, Embryo Transfer 1) Unmarried patients. 2) The patients who are more than 50 years old. 3) The patients undergoing hysterectomies. 4) The patients whose cancers, hematological diseases, or immune disorders have progressed at the time of embryo transfer.

研究者

相似试验